Co-Diagnostics (CODX) Misses Q1 EPS by 10c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c